Adrenergic signaling: a targetable checkpoint limiting development of the antitumor immune response

G Qiao, M Chen, MJ Bucsek, EA Repasky… - Frontiers in …, 2018 - frontiersin.org
An immune response must be tightly controlled so that it will be commensurate with the level
of response needed to protect the organism without damaging normal tissue. The roles of …

Propranolol promotes glucose dependence and synergizes with dichloroacetate for anti-cancer activity in HNSCC

CT Lucido, WK Miskimins, PD Vermeer - Cancers, 2018 - mdpi.com
Tumor cell metabolism differs from that of normal cells, conferring tumors with metabolic
advantages but affording opportunities for therapeutic intervention. Accordingly, metabolism …

Anti-hypertensive medication use, soluble receptor for glycation end products and risk of pancreatic cancer in the Women's Health Initiative Study

Z Wang, DL White, R Hoogeveen, L Chen… - Journal of clinical …, 2018 - mdpi.com
Pancreatic cancer is the fourth leading cause of cancer death. Soluble receptor for glycation
end products (sRAGE), which is modulated by anti-hypertensive (HT) medications, has been …

β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway

MB Xiao, DD Jin, YJ Jiao, WK Ni, JX Liu, LS Qu… - Molecular biology …, 2018 - Springer
Psychological stress has been recognized as a well-documented risk factor associated with
β2-adrenergic receptor (β2-AR) in the development of pancreatic cancer. Aldo–keto …

[HTML][HTML] Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma

X Kuang, M Qi, C Peng, C Zhou, J Su, W Zeng, H Liu… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Both sunitinib, a multi-target tyrosine kinase inhibitor (TKI) and propranolol, a non-selective
β-blocker, have proven therapeutic effects on malignant melanoma (MM). This study reports …

Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor …

SH Yang, TY Lee, CA Ho, CY Yang, WY Huang… - PLoS …, 2018 - journals.plos.org
Long-term nicotine-derived nitrosamine ketone (NNK) and arecoline exposure promotes
carcinogenesis and head and neck squamous cell carcinoma (HNSCC) progression …

β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC

CT Lucido, JL Callejas-Valera, PL Colbert… - Oncogenesis, 2018 - nature.com
The incidence of human papillomavirus-associated head and neck squamous cell
carcinoma (HPV [+] HNSCC) is rapidly increasing. Although clinical management of primary …

Growth inhibition of human hepatocellular carcinoma cells by antagonism of the β2 adrenergic receptor

D Dang, J Zhang, J Yang - Oncology letters, 2018 - spandidos-publications.com
Previous studies have shown that the activation of the β2 adrenergic receptor (ADRB2) can
stimulate several signaling pathways that promote tumor growth and metastasis. β …

The nervous system: a new target in the fight against cancer

R Kazi, YL Bunimovich - Anti-Cancer Drugs, 2018 - journals.lww.com
During cancer progression, tumor cells interact with the neighboring environment, including
neuronal tissue. The important influence of the nervous system on growth and metastasis of …

Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study)

A Vallard, C Rancoule, S Espenel, MA Garcia… - Radiotherapy and …, 2018 - Elsevier
Background Safety profile of the interaction between anticancer drugs and radiation is a
recurrent question. However, there are little data regarding the non-anticancer treatment …